Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 3342 | 1931 | 33.5 | 74% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1211 | 8738 | AMYLOIDOSIS//TRANSTHYRETIN//AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | TRANSTHYRETIN | Author keyword | 561 | 60% | 32% | 617 |
| 2 | FAMILIAL AMYLOIDOTIC POLYNEUROPATHY | Author keyword | 329 | 87% | 8% | 163 |
| 3 | FAMILIAL AMYLOID POLYNEUROPATHY | Author keyword | 206 | 79% | 7% | 133 |
| 4 | AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS | Journal | 75 | 29% | 11% | 218 |
| 5 | AMYLOID UNIT | Address | 56 | 84% | 2% | 31 |
| 6 | FAMILIAL AMYLOIDOTIC POLYNEUROPATHY FAP | Author keyword | 38 | 89% | 1% | 17 |
| 7 | TRANSTHYRETIN TTR | Author keyword | 30 | 69% | 1% | 25 |
| 8 | ESTUDOS PARAMILOIDOSE | Address | 27 | 74% | 1% | 20 |
| 9 | DOMINO LIVER TRANSPLANTATION | Author keyword | 26 | 87% | 1% | 13 |
| 10 | SENILE SYSTEMIC AMYLOIDOSIS | Author keyword | 22 | 62% | 1% | 23 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PRE ALBUMIN | 255 | 74% | 10% | 189 |
| 2 | PORTUGUESE TYPE | 159 | 90% | 4% | 70 |
| 3 | FAMILIAL AMYLOIDOTIC POLYNEUROPATHY | 154 | 64% | 8% | 151 |
| 4 | SENILE SYSTEMIC AMYLOIDOSIS | 152 | 73% | 6% | 117 |
| 5 | PREALBUMIN | 131 | 47% | 11% | 206 |
| 6 | VAL30MET | 98 | 100% | 2% | 29 |
| 7 | HEREDITARY AMYLOIDOSIS | 66 | 53% | 5% | 87 |
| 8 | WILD TYPE TRANSTHYRETIN | 58 | 83% | 2% | 33 |
| 9 | PROTEIN TRANSTHYRETIN | 56 | 89% | 1% | 25 |
| 10 | POLYNEUROPATHY TYPE I | 49 | 94% | 1% | 17 |
Journals |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS | 75 | 29% | 11% | 218 |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Recent progress in the understanding and treatment of transthyretin amyloidosis | 2014 | 10 | 93 | 88% |
| Familial amyloid polyneuropathy | 2011 | 93 | 81 | 68% |
| The molecular biology and clinical features of amyloid neuropathy | 2007 | 140 | 62 | 85% |
| The Transthyretin Amyloidoses: From Delineating the Molecular Mechanism of Aggregation Linked to Pathology to a Regulatory-Agency-Approved Drug | 2012 | 69 | 156 | 71% |
| FAP Neuropathy and Emerging Treatments | 2014 | 7 | 59 | 90% |
| Structure-based design of kinetic stabilizers that ameliorate the transthyretin amyloidoses | 2010 | 74 | 61 | 89% |
| Transthyretin-related familial amyloidotic polyneuropathy | 2005 | 168 | 29 | 93% |
| Liver Transplantation in Transthyretin Amyloidosis: Issues and Challenges | 2015 | 1 | 63 | 92% |
| Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: A focus on the transthyretin amyloidoses | 2005 | 137 | 67 | 81% |
| Pathogenesis of and Therapeutic Strategies to Ameliorate the Transthyretin Amyloidoses | 2008 | 63 | 129 | 77% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | AMYLOID UNIT | 56 | 84% | 1.6% | 31 |
| 2 | ESTUDOS PARAMILOIDOSE | 27 | 74% | 1.0% | 20 |
| 3 | UNIDADE CLIN PARAMILOIDOSE | 11 | 65% | 0.6% | 11 |
| 4 | DIAGNOST MED | 11 | 15% | 3.6% | 70 |
| 5 | GRP ESTUDIO | 8 | 100% | 0.3% | 5 |
| 6 | UNIDADE AMILOIDE | 6 | 80% | 0.2% | 4 |
| 7 | UNIDADE TRANSPLANTACAO | 6 | 71% | 0.3% | 5 |
| 8 | AMYLOID TREATMENT PROGRAM | 5 | 22% | 1.0% | 20 |
| 9 | DISCIPLINES MED OBSTET GYNAECOL | 4 | 75% | 0.2% | 3 |
| 10 | MOL STRUCT UNIT | 4 | 56% | 0.3% | 5 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000130892 | AMYLOIDOSIS//AL AMYLOIDOSIS//AMYLOIDOMA |
| 2 | 0.0000112461 | THYROXINE BINDING GLOBULIN//ENVIRONM MED ENDOCRINOL METAB//TBG |
| 3 | 0.0000111510 | RETINOL BINDING PROTEIN 4//RBP4//STRA6 |
| 4 | 0.0000044404 | CHOROID PLEXUS//EMBRYONIC CEREBROSPINAL FLUID//DESARROLLO TERATOL SISTEMA NERVIOSO |
| 5 | 0.0000040648 | AMYLOID FIBRIL//AMYLOID FIBRILS//AMYLOID |
| 6 | 0.0000035482 | L THREO 3 4 DIHYDROXYPHENYLSERINE//3 4 DIHYDROXYPHENYLSERINE//AMINE PRECURSOR THERAPY |
| 7 | 0.0000033992 | SERUM AMYLOID A//AMYLOID ENHANCING FACTOR//AA AMYLOID |
| 8 | 0.0000032396 | TCHRF//VITAMIN A THERAPEUTIC USE//ALVEOLAR REGENERATION |
| 9 | 0.0000032279 | URICASE//UNIT ANALYT PROBES PROT BIOTECHNOLEDUC MINIST//ALLANTOIN |
| 10 | 0.0000026287 | ALLOGRAFT RE USE//ENDOKARDITIS//LIVER TRANSPLANTAION |